The Use of GnRH Agonist Trigger in the Prevention of OHSS
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
To compare the incidence of ovarian hyperstimulation syndrome (OHSS) and implantation rate
between high responder patients using Gonadotropin releasing GnRH) agonist or human chorionic
gonadotropin (hCG) to trigger final oocyte maturation.